APA način citiranja (7. izdanje)

Leng, H., & Simon, K. (2019). Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease.

Čikaški stil citiranja (17. izdanje)

Leng, H., i K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.

MLA način citiranja (9. izdanje)

Leng, H., i K. Simon. Translational Potential of a Novel Osteoclast Inhibitor, Eliglustat, in Myeloma Bone Disease. 2019.